Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Poulton Stuart sold 403 Karyopharm Therapeutics Inc. shares (Form 4)
Traded May 13 to May 14, 2026 · Filed May 15, 2026
From May 13 to May 14, 2026, Poulton Stuart (EVP, Chief Development Officer) sold 403 Karyopharm Therapeutics Inc. shares at US$9.50 for US$3,829, leaving 94,821 shares. Filed May 15, 2026 (Form 4).
- Sold
- 403 shares
- Price
- US$9.50
- Value
- US$3,829
- Holding after
- 94,821 shares
- Trading plan
- No
- Role
- EVP, Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Award | 896 | 95,224 | Direct | |
| May 14, 2026 | Common Stock | Sale | 403 | US$9.50 | 94,821 | Direct |
Source
Related
- Karyopharm Therapeutics Inc.
- Poulton Stuart
- Karyopharm Therapeutics Inc. shareholders
- Form 4 · Poulton Stuart · Jul 30, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026